0000899243-22-016641.txt : 20220504 0000899243-22-016641.hdr.sgml : 20220504 20220504171057 ACCESSION NUMBER: 0000899243-22-016641 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220502 FILED AS OF DATE: 20220504 DATE AS OF CHANGE: 20220504 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sanna Bastiano CENTRAL INDEX KEY: 0001829069 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 22892547 MAIL ADDRESS: STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED STREET 2: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-05-02 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001829069 Sanna Bastiano C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 0 1 0 0 EVP, Cell & Genetic Therapies Common Stock 2022-05-02 4 S 0 20 255.47 D 41996 D Common Stock 2022-05-02 4 S 0 90 257.49 D 41906 D Common Stock 2022-05-02 4 S 0 43 258.46 D 41863 D Common Stock 2022-05-02 4 S 0 75 259.58 D 41788 D Common Stock 2022-05-02 4 S 0 23 260.44 D 41765 D Common Stock 2022-05-02 4 S 0 65 261.79 D 41700 D Common Stock 2022-05-02 4 S 0 4 264.37 D 41696 D Transaction made pursuant to Dr. Sanna's company approved trading plan under Rule 10b5-1. Dr. Sanna undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $255.47 (range $255.23 to $255.70). Open market sales reported on this line occurred at a weighted average price of $257.49 (range $257.05 to $257.87). Open market sales reported on this line occurred at a weighted average price of $258.46 (range $258.11 to $258.93). Open market sales reported on this line occurred at a weighted average price of $259.58 (range $259.24 to $260.07). Open market sales reported on this line occurred at a weighted average price of $260.44 (range $260.35 to $261.31). Open market sales reported on this line occurred at a weighted average price of $261.79 (range $261.39 to $262.23). /s/ Sabrina Yohai, Attorney-in-Fact 2022-05-04